Search Reports:

Enter company name or symbol or keyword from report title or report description. You can also use our advanced search option to further filter your results.

Accuracy of Opinions

984 (79%) - Correct
255 (21%) - Incorrect

Explanation

Recent News on Covered Stocks

Services

 

New BioMedicine provides a host of customized services to cater to the varied requirements of different investor.  Our services include (but are not limited to):

 

 Email alerts for reports written on specific companies/drugs/diseases    -                                                               No Charge

                                      

Customized analysis of a biotechnology company/drug/event                  -                                                                $3000/report

 

Analyst consultation over phone on companies/drugs/events covered by New BioMedicine       -                                      $ 350/hour

 

Trader consultation over phone on trading strategies based on our universe of coverage           -                                      $1500/hour

 

Healthcare conference coverage  -          $2500/day

 

Detailed reports on specific diseases (i.e., Swine Flu, etc)   -                                                                 $3000/report

 

Please email us at:   kpaul@newbiomedicine.com or call us at: (415) 367-3525, to inquire about these services in further detail.

 

 

How Diseases Work?

Following are the pictorial representation of the most prevalent diseaes:

Breast cancer HCV infection Rheumatoid Arthritis

Sample Report:

VRTX's HCV drug Telaprevir received FDA approval on May 23, 2011. New BioMedicine had issued a report on this event on May 3, 2011. To read more about the drug, the disease, the market, the competition, etc. access it at the link below.

 

Basket Reports:

Free Basket Reports

Specific theme-based reports at a value price

View Package